title: [Combined therapy with mitoxantrone and cytosine arabinoside as a first-line treatment in ANLL: preliminary results].
authors.forename: J A
authors.initials: JA
authors.lastname: Angós
authors.forename: M
authors.initials: M
authors.lastname: Gutiérrez
authors.forename: J A
authors.initials: JA
authors.lastname: Moreno
authors.forename: M J
authors.initials: MJ
authors.lastname: Aguado
authors.forename: M S
authors.initials: MS
authors.lastname: Romero
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D003561:Cytarabine; D008942:Mitoxantrone
vernacular_title: Terapéutica combinada con mitoxantrone y arabinósido de citosina como tratamiento de primera linea en LANL: resultados preliminares.